KAKKIS EMIL D (CIK 1248093) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-20). Recent activity: Buy RARE (76,745 shares), Buy RARE (71,177 shares), Sell RARE (54,404 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-20 | Ultragenyx Pharmaceutical Inc. (RARE) | President & CEO | Buy | 76,745 | $0 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | President & CEO | Buy | 71,177 | $0 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | President & CEO | Sell | 54,404 | $1.2M |
来源：SEC Form 4 申报文件 · 截至 2026-04-20